| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.084 | 0.2 |